2020
Olanzapine for the Prevention of Postdischarge Nausea and Vomiting after Ambulatory Surgery: A Randomized Controlled Trial.
Hyman JB, Park C, Lin HM, Cole B, Rosen L, Fenske SS, Barr Grzesh RL, Blank SV, Polsky SB, Hartnett M, Taub PJ, Palvia V, DeMaria S, Ascher-Walsh C. Olanzapine for the Prevention of Postdischarge Nausea and Vomiting after Ambulatory Surgery: A Randomized Controlled Trial. Anesthesiology 2020, 132: 1419-1428. PMID: 32229754, DOI: 10.1097/aln.0000000000003286.Peer-Reviewed Original ResearchConceptsOlanzapine groupPlacebo groupAmbulatory surgeryPostdischarge nauseaSevere nauseaFemale patients 50 yearsStandard antiemetic prophylaxisPlacebo-controlled studyPlacebo-controlled trialPrimary composite outcomeSingle preoperative dosePatients 50 yearsRisk of nauseaAddition of olanzapineAntiemetic prophylaxisOlanzapine 10Preoperative doseComposite outcomeSecondary outcomesControlled TrialsPrimary outcomeOral olanzapineGeneral anesthesiaNauseaVomiting
2010
Scheduled and unscheduled hospital readmissions among patients with diabetes.
Kim H, Ross JS, Melkus GD, Zhao Z, Boockvar K. Scheduled and unscheduled hospital readmissions among patients with diabetes. The American Journal Of Managed Care 2010, 16: 760-7. PMID: 20964472, PMCID: PMC3024140.Peer-Reviewed Original ResearchConceptsUnscheduled readmissionsIndex hospitalizationHigher comorbidity burdenState Inpatient DatasetPatients 80 yearsPatients 50 yearsHistory of hospitalizationAcute care hospitalsPrevention Quality IndicatorsUnscheduled hospital readmissionComorbidity burdenOlder patientsCare hospitalClinical factorsHospital readmissionIll patientsInpatient datasetTransition careReadmissionHospitalizationPatientsDiabetesPublic insuranceHealthcare ResearchPotential disparities
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply